Adjuvant Treatment With Interleukin-2- and Interferon-Alpha2a-Based Chemoimmunotherapy in Renal Cell Carcinoma Post Tumour Nephrectomy: Results of a Prospectively Randomised Trial of the German Cooperative Renal Carcinoma Chemoimmunotherapy Group (DGCIN)
Titel:
Adjuvant Treatment With Interleukin-2- and Interferon-Alpha2a-Based Chemoimmunotherapy in Renal Cell Carcinoma Post Tumour Nephrectomy: Results of a Prospectively Randomised Trial of the German Cooperative Renal Carcinoma Chemoimmunotherapy Group (DGCIN)
Auteur:
Atzpodien, J. Schmitt, E. Gertenbach, U. Fornara, P. Heynemann, H. Maskow, A. Ecke, M. Wöltjen, H.H. Jentsch, H. Wieland, W. Wandert, T. Reitz, M.